✦ LIBER ✦

A Benefit-Risk Assessment of Agents Used in the Secondary Prevention of Stroke

✍ Scribed by Dr Ronald S. MacWalter, Colin P. Shirley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Statins in the secondary prevention of s

✍ Luis Castilla-Guerra; María del Carmen Fernández-Moreno; Jesús Alvarez-Suero 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Clinical Pharmacokinetics of Antiplatele

✍ Dr Thomas L. Lenz, Amy F. Wilson 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 141 KB

Assessing the risks, benefits and costs

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Antiplatelet agents for secondary preven

✍ Richard A. Bernstein 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 104 KB

A Risk-Benefit Assessment of the Newer O

✍ Dr Aditya K. Gupta, Neil H. Shear 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 235 KB

Benefit–Risk Assessment of Dabigatran in

✍ Meyer dos Santos, Sascha; Harder, Sebastian 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 446 KB